Related by context. Frequent words. (Click for all words.) 70 Pharmion Corporation 68 OncoGenex Pharmaceuticals Inc. 67 refractory chronic lymphocytic 66 R sorafenib tablets 66 ZALBIN 65 Inc. Nasdaq IMGN 65 Nasdaq VRTX 65 Ixempra 65 Inc Therapeutic Competitors 64 elotuzumab 64 NASDAQ OSIR 64 NASDAQ CRXL 64 NASDAQ ARIA 64 Nasdaq ISIS 64 GlaxoSmithKline plc GSK 64 Crucell NV Euronext 64 Merck Serono division 63 Nexavar ® 63 NASDAQ IMCL 63 Advancing Drugs 62 ImmunoCellular Therapeutics 62 Panzem R 62 Nasdaq BIIB 62 Initiate Phase 62 Inc. Nasdaq SGEN 62 Idera Pharmaceuticals 62 Regulus Therapeutics 62 Hybridon 62 Gemzar ® 61 Tibotec Pharmaceuticals 61 Nasdaq REGN 61 Chemokine Therapeutics 61 Archemix Corp. 61 Dynavax Technologies Corporation 61 Amrubicin 61 Array BioPharma Inc. 61 Genaera Corporation 61 Ligand Pharmaceuticals Incorporated 61 Pivotal Phase III 61 LIVALO 61 NASDAQ BPAX 61 Allovectin 7 R 61 Amarillo Biosciences Inc. 61 ocrelizumab 60 Bicifadine 60 NASDAQ CELG 60 MicroDose 60 Paladin Labs 60 Scancell 60 Nasdaq ALTH 60 Oscient Pharmaceuticals 60 Idenix Pharmaceuticals 60 AVEO Pharmaceuticals Inc. 60 apaziquone 60 Lorus Therapeutics 60 DepoMed 60 Metabasis Therapeutics Inc. 60 SCHWARZ PHARMA 60 NASDAQ SHPGY 60 Actelion Ltd 60 Onalta 60 Mipomersen 60 ridaforolimus 60 Kyowa Hakko Kirin 60 ImClone Systems Incorporated 60 Addrenex 60 Aradigm Corporation 60 Regado Biosciences 60 Ironwood Pharmaceuticals Inc. 60 Nasdaq CELG 60 Entereg R 59 Hana Biosciences 59 Trubion Pharmaceuticals Inc. 59 DAVANAT 59 NovaBay Pharmaceuticals 59 ImmunoGen Inc. 59 AEterna Zentaris Inc. 59 BioSpecifics Technologies Corp. 59 MOZOBIL 59 Genelabs Technologies Inc. 59 AnGes 59 FDA Accepts 59 Inc. Nasdaq EXEL 59 Immunomedics Inc. 59 AVEO Pharmaceuticals 59 ImmuneRegen BioSciences Inc. 59 Immunogen 59 anti CD# monoclonal 59 CoTherix Inc. 59 Genentech Roche 59 Progenics Pharmaceuticals 59 IDIX 59 Alexza Pharmaceuticals Inc. 59 Phase III Trial 59 Combidex 59 Inc. NASDAQ CLDA 59 Tolerx 59 Synergy Pharmaceuticals 59 SciClone Pharmaceuticals 59 novel antibody therapeutics 59 atacicept